AI assistant
Beta Bionics, Inc. — Director's Dealing 2025
Jun 5, 2025
32351_dirs_2025-06-04_42cdefa3-8b15-4c7a-8abd-7b98883d6464.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-06-02
Reporting Person: Saint Sean (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-02 | Common Stock | S | 943 | $17.028 | Disposed | 107057 | Direct |
| 2025-06-02 | Common Stock | S | 2185 | $18.1489 | Disposed | 104872 | Direct |
| 2025-06-02 | Common Stock | S | 311 | $18.691 | Disposed | 104561 | Direct |
Footnotes
F1: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
F2: The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F3: The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F4: The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.